nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR1B—trigeminal nerve—head and neck cancer	0.0924	0.129	CbGeAlD
Oxymetazoline—HTR1D—trigeminal nerve—head and neck cancer	0.0894	0.125	CbGeAlD
Oxymetazoline—NISCH—Paclitaxel—Docetaxel—head and neck cancer	0.0683	0.645	CbGdCrCtD
Oxymetazoline—HTR1B—cranial nerve—head and neck cancer	0.0658	0.0918	CbGeAlD
Oxymetazoline—HTR1D—cranial nerve—head and neck cancer	0.0637	0.0889	CbGeAlD
Oxymetazoline—HTR2A—trigeminal nerve—head and neck cancer	0.0444	0.062	CbGeAlD
Oxymetazoline—NISCH—hair follicle—head and neck cancer	0.0438	0.0612	CbGeAlD
Oxymetazoline—NISCH—Vincristine—Vinblastine—head and neck cancer	0.0375	0.355	CbGdCrCtD
Oxymetazoline—HTR2A—cranial nerve—head and neck cancer	0.0317	0.0442	CbGeAlD
Oxymetazoline—NISCH—parotid gland—head and neck cancer	0.024	0.0334	CbGeAlD
Oxymetazoline—NISCH—trachea—head and neck cancer	0.0177	0.0247	CbGeAlD
Oxymetazoline—HTR1E—head—head and neck cancer	0.0169	0.0236	CbGeAlD
Oxymetazoline—ADRA1D—epithelium—head and neck cancer	0.0167	0.0233	CbGeAlD
Oxymetazoline—NISCH—thyroid gland—head and neck cancer	0.014	0.0195	CbGeAlD
Oxymetazoline—HTR1D—connective tissue—head and neck cancer	0.0132	0.0183	CbGeAlD
Oxymetazoline—ADRA2C—parotid gland—head and neck cancer	0.0109	0.0153	CbGeAlD
Oxymetazoline—ADRA1B—head—head and neck cancer	0.0106	0.0148	CbGeAlD
Oxymetazoline—ADRA1D—head—head and neck cancer	0.0104	0.0145	CbGeAlD
Oxymetazoline—ADRA1A—epithelium—head and neck cancer	0.00959	0.0134	CbGeAlD
Oxymetazoline—HTR2A—neck—head and neck cancer	0.00911	0.0127	CbGeAlD
Oxymetazoline—NISCH—lymph node—head and neck cancer	0.0087	0.0121	CbGeAlD
Oxymetazoline—HTR2B—thyroid gland—head and neck cancer	0.00812	0.0113	CbGeAlD
Oxymetazoline—ADRA2C—trachea—head and neck cancer	0.00808	0.0113	CbGeAlD
Oxymetazoline—HTR1B—head—head and neck cancer	0.008	0.0112	CbGeAlD
Oxymetazoline—HTR1D—head—head and neck cancer	0.00775	0.0108	CbGeAlD
Oxymetazoline—ADRA2A—connective tissue—head and neck cancer	0.00768	0.0107	CbGeAlD
Oxymetazoline—HTR2C—head—head and neck cancer	0.00767	0.0107	CbGeAlD
Oxymetazoline—ADRA1A—lymphoid tissue—head and neck cancer	0.00739	0.0103	CbGeAlD
Oxymetazoline—HTR2B—head—head and neck cancer	0.00721	0.0101	CbGeAlD
Oxymetazoline—HTR2A—connective tissue—head and neck cancer	0.00653	0.00911	CbGeAlD
Oxymetazoline—ADRA2A—trachea—head and neck cancer	0.00645	0.009	CbGeAlD
Oxymetazoline—HTR2A—epithelium—head and neck cancer	0.0062	0.00865	CbGeAlD
Oxymetazoline—ADRA1A—head—head and neck cancer	0.00595	0.00831	CbGeAlD
Oxymetazoline—ADRA2C—head—head and neck cancer	0.00567	0.00791	CbGeAlD
Oxymetazoline—HTR2A—trachea—head and neck cancer	0.00548	0.00765	CbGeAlD
Oxymetazoline—ADRA2A—thyroid gland—head and neck cancer	0.0051	0.00712	CbGeAlD
Oxymetazoline—HTR2B—lymph node—head and neck cancer	0.00505	0.00704	CbGeAlD
Oxymetazoline—ADRA2A—head—head and neck cancer	0.00453	0.00632	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—head and neck cancer	0.00397	0.00554	CbGeAlD
Oxymetazoline—HTR2A—head—head and neck cancer	0.00385	0.00537	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—head and neck cancer	0.00317	0.00442	CbGeAlD
Oxymetazoline—HTR1E—Signaling Pathways—STAT3—head and neck cancer	8.1e-05	0.000456	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—PIK3CA—head and neck cancer	8.07e-05	0.000455	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—AKT1—head and neck cancer	8.06e-05	0.000454	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL2—head and neck cancer	7.97e-05	0.000449	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—PIK3CA—head and neck cancer	7.91e-05	0.000446	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	7.85e-05	0.000442	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	7.84e-05	0.000442	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	7.77e-05	0.000438	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	7.77e-05	0.000438	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MAPK3—head and neck cancer	7.74e-05	0.000436	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	7.67e-05	0.000433	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—MAPK3—head and neck cancer	7.6e-05	0.000428	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—AKT1—head and neck cancer	7.53e-05	0.000425	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	7.49e-05	0.000422	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	7.43e-05	0.000419	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MAPK1—head and neck cancer	7.36e-05	0.000415	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EGFR—head and neck cancer	7.36e-05	0.000415	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—PIK3CA—head and neck cancer	7.33e-05	0.000413	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NOTCH1—head and neck cancer	7.33e-05	0.000413	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—head and neck cancer	7.25e-05	0.000408	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—MAPK1—head and neck cancer	7.23e-05	0.000408	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—EGFR—head and neck cancer	7.23e-05	0.000407	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—PIK3CA—head and neck cancer	7.18e-05	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	7.13e-05	0.000402	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL2—head and neck cancer	7.12e-05	0.000401	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	7.04e-05	0.000397	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	6.97e-05	0.000393	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—HRAS—head and neck cancer	6.93e-05	0.000391	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—PIK3CA—head and neck cancer	6.91e-05	0.000389	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—MAPK3—head and neck cancer	6.86e-05	0.000387	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOTCH1—head and neck cancer	6.84e-05	0.000386	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—HRAS—head and neck cancer	6.78e-05	0.000382	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	6.74e-05	0.00038	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	6.74e-05	0.00038	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—HRAS—head and neck cancer	6.64e-05	0.000374	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—AKT1—head and neck cancer	6.6e-05	0.000372	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	6.59e-05	0.000371	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	6.53e-05	0.000368	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	6.53e-05	0.000368	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL2—head and neck cancer	6.53e-05	0.000368	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	6.48e-05	0.000365	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—AKT1—head and neck cancer	6.46e-05	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—MAPK3—head and neck cancer	6.41e-05	0.000361	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL2—head and neck cancer	6.39e-05	0.00036	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—PIK3CA—head and neck cancer	6.39e-05	0.00036	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCND1—head and neck cancer	6.36e-05	0.000358	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	6.31e-05	0.000355	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—PIK3CA—head and neck cancer	6.28e-05	0.000354	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	6.27e-05	0.000353	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	6.27e-05	0.000353	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	6.24e-05	0.000352	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	6.24e-05	0.000352	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCND1—head and neck cancer	6.23e-05	0.000351	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—head and neck cancer	6.18e-05	0.000348	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PTEN—head and neck cancer	6.14e-05	0.000346	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—AKT1—head and neck cancer	6.12e-05	0.000345	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	6.11e-05	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—MAPK1—head and neck cancer	6.1e-05	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—head and neck cancer	6.1e-05	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—head and neck cancer	6.08e-05	0.000342	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	6.07e-05	0.000342	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PTEN—head and neck cancer	6.01e-05	0.000339	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	6e-05	0.000338	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL2—head and neck cancer	6e-05	0.000338	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	6e-05	0.000338	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	5.99e-05	0.000338	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	5.99e-05	0.000338	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	5.98e-05	0.000337	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HRAS—head and neck cancer	5.91e-05	0.000333	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	5.86e-05	0.000331	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCND1—head and neck cancer	5.85e-05	0.00033	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—PIK3CA—head and neck cancer	5.83e-05	0.000328	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	5.81e-05	0.000327	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	5.74e-05	0.000323	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	5.72e-05	0.000322	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	5.67e-05	0.000319	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PTEN—head and neck cancer	5.65e-05	0.000318	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	5.65e-05	0.000318	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	5.6e-05	0.000316	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL2—head and neck cancer	5.58e-05	0.000315	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	5.56e-05	0.000313	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	5.55e-05	0.000313	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	5.51e-05	0.00031	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—STAT3—head and neck cancer	5.49e-05	0.000309	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	5.44e-05	0.000307	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	5.44e-05	0.000307	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	5.44e-05	0.000307	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	5.44e-05	0.000307	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	5.43e-05	0.000306	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—head and neck cancer	5.38e-05	0.000303	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	5.33e-05	0.0003	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	5.33e-05	0.0003	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTEN—head and neck cancer	5.3e-05	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—PIK3CA—head and neck cancer	5.29e-05	0.000298	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	5.25e-05	0.000296	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	5.25e-05	0.000296	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	5.24e-05	0.000295	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—head and neck cancer	5.22e-05	0.000294	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	5.21e-05	0.000294	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	5.21e-05	0.000293	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.2e-05	0.000293	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	5.14e-05	0.000289	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	5.13e-05	0.000289	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	5.1e-05	0.000287	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	5.1e-05	0.000287	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.09e-05	0.000287	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—head and neck cancer	5.05e-05	0.000285	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL2—head and neck cancer	5.04e-05	0.000284	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	5.03e-05	0.000284	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	4.99e-05	0.000281	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—head and neck cancer	4.99e-05	0.000281	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	4.95e-05	0.000279	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	4.95e-05	0.000279	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—head and neck cancer	4.94e-05	0.000278	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	4.92e-05	0.000277	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	4.9e-05	0.000276	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	4.89e-05	0.000276	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	4.89e-05	0.000275	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—head and neck cancer	4.89e-05	0.000275	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2—head and neck cancer	4.84e-05	0.000273	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	4.83e-05	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	4.82e-05	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	4.76e-05	0.000268	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	4.75e-05	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	4.74e-05	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.73e-05	0.000267	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	4.72e-05	0.000266	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCND1—head and neck cancer	4.72e-05	0.000266	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2—head and neck cancer	4.71e-05	0.000265	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	4.7e-05	0.000265	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	4.69e-05	0.000264	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2—head and neck cancer	4.64e-05	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	4.63e-05	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	4.63e-05	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	4.59e-05	0.000259	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	4.59e-05	0.000259	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—head and neck cancer	4.59e-05	0.000259	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTEN—head and neck cancer	4.56e-05	0.000257	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	4.52e-05	0.000255	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	4.49e-05	0.000253	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	4.44e-05	0.00025	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	4.43e-05	0.00025	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	4.37e-05	0.000246	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	4.36e-05	0.000246	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	4.33e-05	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	4.32e-05	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTEN—head and neck cancer	4.3e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	4.3e-05	0.000242	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	4.28e-05	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	4.28e-05	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	4.27e-05	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	4.27e-05	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	4.25e-05	0.00024	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	4.25e-05	0.00024	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	4.24e-05	0.000239	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	4.24e-05	0.000239	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2—head and neck cancer	4.2e-05	0.000237	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—head and neck cancer	4.19e-05	0.000236	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	4.16e-05	0.000235	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2—head and neck cancer	4.12e-05	0.000232	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	4.12e-05	0.000232	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—head and neck cancer	4.1e-05	0.000231	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCND1—head and neck cancer	4.1e-05	0.000231	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—head and neck cancer	4.07e-05	0.00023	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	4.05e-05	0.000228	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	4.01e-05	0.000226	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRAS—head and neck cancer	4.01e-05	0.000226	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	4e-05	0.000226	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	3.98e-05	0.000225	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	3.98e-05	0.000224	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	3.96e-05	0.000223	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTEN—head and neck cancer	3.96e-05	0.000223	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	3.94e-05	0.000222	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRAS—head and neck cancer	3.92e-05	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	3.9e-05	0.00022	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	3.89e-05	0.000219	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	3.87e-05	0.000218	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	3.87e-05	0.000218	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	3.86e-05	0.000218	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	3.86e-05	0.000217	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	3.86e-05	0.000217	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—head and neck cancer	3.85e-05	0.000217	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2—head and neck cancer	3.83e-05	0.000216	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	3.79e-05	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	3.78e-05	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3CA—head and neck cancer	3.74e-05	0.000211	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	3.73e-05	0.00021	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	3.73e-05	0.00021	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	3.71e-05	0.000209	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	3.7e-05	0.000209	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—head and neck cancer	3.7e-05	0.000209	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRAS—head and neck cancer	3.69e-05	0.000208	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	3.6e-05	0.000203	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	3.6e-05	0.000203	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	3.6e-05	0.000203	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—head and neck cancer	3.59e-05	0.000202	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	3.57e-05	0.000201	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	3.55e-05	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	3.54e-05	0.0002	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—head and neck cancer	3.54e-05	0.000199	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—head and neck cancer	3.54e-05	0.000199	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	3.51e-05	0.000198	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	3.5e-05	0.000197	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	3.46e-05	0.000195	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—head and neck cancer	3.46e-05	0.000195	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	3.43e-05	0.000193	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	3.38e-05	0.000191	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	3.35e-05	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	3.31e-05	0.000187	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—head and neck cancer	3.25e-05	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	3.25e-05	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—head and neck cancer	3.24e-05	0.000182	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	3.22e-05	0.000181	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	3.22e-05	0.000181	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—head and neck cancer	3.22e-05	0.000181	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	3.21e-05	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	3.15e-05	0.000177	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	3.15e-05	0.000177	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	3.13e-05	0.000176	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—head and neck cancer	3.11e-05	0.000175	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	3.1e-05	0.000174	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	3.08e-05	0.000173	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	3.08e-05	0.000173	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—head and neck cancer	3.05e-05	0.000172	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CA—head and neck cancer	3.04e-05	0.000171	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	3.03e-05	0.000171	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—head and neck cancer	3.02e-05	0.00017	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—head and neck cancer	2.98e-05	0.000168	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRAS—head and neck cancer	2.97e-05	0.000168	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	2.93e-05	0.000165	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	2.93e-05	0.000165	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	2.89e-05	0.000163	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	2.85e-05	0.00016	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	2.79e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	2.73e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	2.73e-05	0.000154	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—head and neck cancer	2.7e-05	0.000152	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—head and neck cancer	2.64e-05	0.000149	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—head and neck cancer	2.63e-05	0.000148	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRAS—head and neck cancer	2.58e-05	0.000146	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	2.55e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	2.54e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	2.53e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	2.51e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—head and neck cancer	2.48e-05	0.00014	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—head and neck cancer	2.46e-05	0.000138	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	2.35e-05	0.000132	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—head and neck cancer	2.28e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	2.23e-05	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	2.07e-05	0.000117	CbGpPWpGaD
